DBV Technologies | Efectivo Y Equivalentes



Cash And Equivalent Cambio Fecha
Acadia Pharmaceuticals USD 755.99M 190.66M 2024-12
Alnylam Pharmaceuticals USD 966.43M 133.49M 2024-12
Amarin USD 156.94M 58.98M 2024-09
BioMarin Pharmaceutical USD 613.22M 324.54M 2024-12
DBV Technologies USD 32.5M 4.51M 2024-12
Halozyme Therapeutics USD 115.85M 38.47M 2024-12
Incyte USD 1.69B 383.72M 2024-12
Insmed USD 555.03M 93.58M 2024-12
Ionis Pharmaceuticals USD 242.08M 92.53M 2024-12
Neurocrine Biosciences USD 233M 116.1M 2024-12
PTC Therapeutics USD 779.71M 253.71M 2024-12
Sarepta Therapeutics USD 1.1B 905.16M 2024-12
Ultragenyx Pharmaceutical USD 173.73M 23.11M 2024-12
United Therapeutics USD 1.7B 143.3M 2024-12



DBV Technologies Efectivo Y Equivalentes - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Apr 2025.